We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 32

Europe wants Canada to update patent laws
  • Gowling WLG
  • Canada, European Union
  • March 15 2011

Canada is currently negotiating a comprehensive economic trade agreement with the European Union to increase the volume of trade and business occurring between Canada and Europe.


Generic drug companies complain about lower prices
  • Gowling WLG
  • Canada
  • September 21 2010

As reported on September 13, 2010 in the National Post, representatives of Canadian generic companies, including Apotex, Teva and the Canadian Generic Pharmaceutical Association are warning that lower prices for generic medicines could backfire.


Maker of VODKAT fails to convince Court of Appeal that extended passing off is now too broad
  • Gowling WLG
  • United Kingdom
  • August 26 2010

The Court of Appeal has upheld the judgment of Arnold J in January that Intercontinental Brands (ICB) passed off its VODKAT product as vodka and thereby caused damage to Diageo, manufacturer of the SMIRNOFF brand of vodka.


Provinces and territories discuss joining forces to purchase drugs at lower prices
  • Gowling WLG
  • Canada
  • August 26 2010

On August 6, 2010, Canadian Premiers attended their annual Council of the Federation Premiers' Conference in Winnipeg to discuss a joint alliance among the provinces and territories for purchasing common drugs and medical supplies and equipment for the public sector.


Second phase of Alberta's pharmaceutical strategy aims to reduce drug costs, improve access to new drugs and expand the role of pharmacists
  • Gowling WLG
  • Canada
  • November 2 2009

On October 20, 2009, the Alberta Government released the second phase of the Alberta Pharmaceutical Strategy which indicates that the Government will reduce generic drug prices - the Government states it will reduce the price of new generic drugs from 75 percent of the brand name drug to 45 and announces that its discussions with pharmacists and pharmacies regarding the price reduction will begin this month.


European Court gives boost to selective distribution strategies for luxury trade mark owners
  • Gowling WLG
  • European Union
  • April 24 2009

The European Court of Justice (ECJ) has provided guidance, which strengthens the ability of luxury trade mark owners to maintain and enforce a selective distribution network for branded goods.


E-waste obligations take effect in Ontario
  • Gowling WLG
  • Canada
  • March 31 2009

Ontario’s Minister of the Environment approved the Waste Electrical and Electronic Equipment ("WEEE") Program Plan on July 9, 2008.


Increased competition for generic drugs could save Canadians $800 million a year
  • Gowling WLG
  • Canada
  • November 26 2008

The Competition Bureau has released a new study of the generic drug industry, Benefiting from Generic Drug Competition in Canada: The Way Forward, that proposes a number of changes to increase competition in the supply of generic drugs.


Ontario approves Waste Electrical and Electronic Equipment Program
  • Gowling WLG
  • Canada
  • October 20 2008

The Waste Electrical and Electronic Equipment Program has been approved by Environment Minister John Gerretsen.


EU expands antitrust inquiry of drug companies
  • Gowling WLG
  • European Union
  • May 29 2008

European antitrust regulators are continuing their inquiry into industry and corporate practices in the European pharmaceutical market.